Physician profile
Amanda Hoffman
NPI 1982325155
$6,113.68
in general payments reported to CMS, 2019-2025
32 companies · $1,808 in 2025
The $1,808 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $198 · 2023: $2,771 · 2024: $1,336 · 2025: $1,808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,922 · Travel and Lodging: $902 · Education: $92.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,921.63 |
| Travel and Lodging | $902.13 |
| Education | $92.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,382.13 | 2022-2024 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $870.00 | 2022-2025 | Erleada, Carvykti, Rybrevant |
| Pfizer INC. | $485.32 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $476.12 | 2023-2025 | Gemtesa, Orgovyx |
| 180 Medical, INC. | $362.93 | 2022-2025 | |
| Urogen Pharma, INC. | $346.55 | 2023-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $338.49 | 2023-2024 | Xiaflex, Aveed |
| Abbvie INC. | $304.15 | 2022-2025 | |
| Endo USA, INC. | $242.50 | 2024-2025 | Xiaflex, Aveed |
| Medtronic, INC. | $180.54 | 2023-2024 | Interstim |
| Progenics Pharmaceuticals, INC. | $177.31 | 2023-2025 | Pylarify |
| Astellas Pharma US INC | $168.13 | 2023-2025 | Xtandi, Myrbetriq |
| Immunitybio, INC. | $143.84 | 2024-2025 | |
| Teleflex LLC | $65.46 | 2023-2024 | Urolift |
| Tolmar, INC. | $54.22 | 2025 | Eligard, Jatenzo |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $51.60 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $47.11 | 2025 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $44.34 | 2025 | |
| Blue Earth Diagnostics | $44.21 | 2023-2025 | Posluma |
| Olympus America INC. | $41.69 | 2023-2025 | Itind System |
| C. R. Bard, INC. & Subsidiaries | $39.91 | 2025 | Bard Urinary Drainage Bag |
| Dendreon Pharmaceuticals LLC | $33.22 | 2024 | Provenge |
| Merck Sharp & Dohme LLC | $32.72 | 2024-2025 | Keytruda, Welireg, Zerbaxa |
| Coloplast Corp | $31.14 | 2023-2024 | Altis |
| Procept Biorobotics Corporation | $27.55 | 2023 | Aquabeam Robotic System |
| Kowa Pharmaceuticals America, INC. | $25.97 | 2023 | Seglentis |
| Myovant Sciences INC. | $18.20 | 2022 | |
| Sun Pharmaceutical Industries INC. | $17.42 | 2023 | Yonsa |
| Palette Life Sciences, INC. | $17.07 | 2022 | |
| Foundation Medicine, INC. | $16.05 | 2023 | Foundationone Cdx |
| Photocure INC | $14.01 | 2024 | Cysview |
| Boston Scientific Corporation | $13.78 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.